192 filings
Page 4 of 10
UPLOAD
IKT
Inhibikase Therapeutics Inc
3 Feb 23
Letter from SEC
12:00am
S-1
IKT
Inhibikase Therapeutics Inc
IPO registration
1 Feb 23
9:02pm
SC 13D
FiveT Investment Management Ltd
31 Jan 23
Inhibikase Therapeutics / FiveT Investment Management ownership change
11:59am
424B5
IKT
Inhibikase Therapeutics Inc
27 Jan 23
Prospectus supplement for primary offering
8:25am
8-K
IKT
Inhibikase Therapeutics Inc
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
IKT
Inhibikase Therapeutics Inc
25 Jan 23
Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Parkinson’s Disease
9:00am
8-K
IKT
Inhibikase Therapeutics Inc
24 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:27pm
8-K
IKT
Inhibikase Therapeutics Inc
17 Nov 22
Inhibikase Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity
4:30pm
10-Q
2022 Q3
IKT
Inhibikase Therapeutics Inc
Quarterly report
14 Nov 22
5:10pm
8-K
IKT
Inhibikase Therapeutics Inc
7 Nov 22
Inhibikase Therapeutics Announces FDA Clinical Hold on IkT-148009 Programs
4:01pm
8-K
IKT
Inhibikase Therapeutics Inc
16 Sep 22
Regulation FD Disclosure
4:09pm
4
Gisele Dion
6 Sep 22
Inhibikase Therapeutics / Gisele Dion ownership change
5:08pm
3
IKT
Inhibikase Therapeutics Inc
6 Sep 22
Inhibikase Therapeutics / Gisele Dion ownership change
5:06pm
8-K
IKT
Inhibikase Therapeutics Inc
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
4
IKT
Inhibikase Therapeutics Inc
16 Aug 22
Inhibikase Therapeutics / Milton H. Werner ownership change
4:25pm
8-K
IKT
Inhibikase Therapeutics Inc
15 Aug 22
Regulation FD Disclosure
5:12pm
10-Q
2022 Q2
IKT
Inhibikase Therapeutics Inc
Quarterly report
12 Aug 22
4:33pm
8-K
IKT
Inhibikase Therapeutics Inc
28 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:55pm
8-K
IKT
Inhibikase Therapeutics Inc
29 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
4
Freeman Roy Lester
28 Jun 22
Inhibikase Therapeutics / Roy Lester Freeman ownership change
9:00pm